— Know what they know.
Not Investment Advice

ARYD NASDAQ

ARYA Sciences Acquisition Corp IV
1W: -1.9% 1M: -53.1% 3M: -54.1% 1Y: -50.6% 3Y: -51.5%
$6.64
Last traded 2024-08-22 — delisted
NASDAQ · Financial Services · Shell Companies · $50.0M mcap · 3M float · 0.819% daily turnover

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2023-06-23
Earliest Filing
2023-06-23
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named ARYD in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
SYRE Aeglea BioTherapeutics, Inc. investor Special purpose acquisition company where director Michael Henderson serves on the board of directors. 2023-06-23 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms